These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 21419866

  • 1. Effect of a nanostructured dendrimer-naloxonazine complex on endogenous opioid peptides μ1 receptor-mediated post-ictal antinociception.
    Felippotti TT, do Carmo DR, Paim LL, Stradiotto NR, Bicalho Ude O, Parada CA, Grillo R, Fraceto LF, Coimbra NC.
    Nanomedicine; 2011 Dec; 7(6):871-80. PubMed ID: 21419866
    [Abstract] [Full Text] [Related]

  • 2. Endogenous opioid peptide-mediated neurotransmission in central and pericentral nuclei of the inferior colliculus recruits μ1-opioid receptor to modulate post-ictal antinociception.
    Felippotti TT, de Freitas RL, Coimbra NC.
    Neuropeptides; 2012 Feb; 46(1):39-47. PubMed ID: 22104092
    [Abstract] [Full Text] [Related]

  • 3. µ1 -Opioid receptors in the dorsomedial and ventrolateral columns of the periaqueductal grey matter are critical for the enhancement of post-ictal antinociception.
    de Freitas RL, Medeiros P, Khan AU, Coimbra NC.
    Synapse; 2016 Dec; 70(12):519-530. PubMed ID: 27503688
    [Abstract] [Full Text] [Related]

  • 4. Opioid neurotransmission in the post-ictal analgesia: involvement of mu(1)-opioid receptor.
    Coimbra NC, Freitas RL, Savoldi M, Castro-Souza C, Segato EN, Kishi R, Weltson A, Resende GC.
    Brain Res; 2001 Jun 08; 903(1-2):216-21. PubMed ID: 11382405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D, Watanabe C, Watanabe H, Mizoguchi H, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):109-16. PubMed ID: 17343845
    [Abstract] [Full Text] [Related]

  • 8. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.
    Eur J Pharmacol; 2000 Apr 28; 395(2):107-12. PubMed ID: 10794815
    [Abstract] [Full Text] [Related]

  • 9. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats.
    Verborgh C, Meert TF.
    Pain; 1999 Oct 28; 83(1):17-24. PubMed ID: 10506668
    [Abstract] [Full Text] [Related]

  • 10. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H, Kon-No T, Watanabe H, Watanabe C, Yonezawa A, Sato T, Sakurada T, Sakurada S.
    Peptides; 2013 Dec 28; 50():139-44. PubMed ID: 24126280
    [Abstract] [Full Text] [Related]

  • 11. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys.
    Gatch MB, Liguori A, Negus SS, Mello NK, Bergman J.
    Eur J Pharmacol; 1996 Feb 29; 298(1):31-6. PubMed ID: 8867916
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA, Bodnar RJ, Portzline T, Pasternak GW.
    Pharmacol Biochem Behav; 1986 Jun 29; 24(6):1721-7. PubMed ID: 3016762
    [Abstract] [Full Text] [Related]

  • 13. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y, Fujita Y, Shiotani K, Miyazaki A, Li T, Tsuda Y, Okada Y, Ambo A, Sasaki Y, Bryant SD, Lazarus LH.
    Eur J Pharmacol; 2005 Feb 10; 509(1):37-42. PubMed ID: 15713427
    [Abstract] [Full Text] [Related]

  • 14. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
    Negus SS, Pasternak GW, Koob GF, Weinger MB.
    J Pharmacol Exp Ther; 1993 Feb 10; 264(2):739-45. PubMed ID: 8437122
    [Abstract] [Full Text] [Related]

  • 15. Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia.
    Rebouças EC, Segato EN, Kishi R, Freitas RL, Savoldi M, Morato S, Coimbra NC.
    Psychopharmacology (Berl); 2005 May 10; 179(2):349-55. PubMed ID: 15821952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
    Negri L, Lattanzi R, Tabacco F, Melchiorri P.
    Br J Pharmacol; 1998 May 10; 124(2):345-55. PubMed ID: 9641552
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.